23 October 2017
News and Views
Links and Services
A study in June's issue of the Alimentary Pharmacology & Therapeutics applies pharmacokinetics to optimize dosing of anti-TNF biologics in acute severe ulcerative colitis.
Acute severe ulcerative colitis, the most aggressive presentation of ulcerative colitis (UC), occ
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors